Kurome Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for KME-0584 for the Treatment of Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS) Research Papers / By aisoftware
KUROME THERAPEUTICS TARGETS DYSREGULATED IMMUNE SIGNALING IN BLOOD CANCER PATIENTS Press Release / By aisoftware